Inventor · disambiguated record
Adam Palermo
Also filed as: PALERMO ADAM
9 granted patents·10 pending applications·17 citations·filing 2002–2025
83Inventor score
Top patents by PatentIndex Score
19 records- 0188US12252520B2Myosin 15 promoters and uses thereofDECIBEL THERAPEUTICS INC·Filed 2021·Granted Mar 18, 2025·2 cites·13 claims
- 0288US11660353B2Compositions and methods for treating sensorineural hearing loss using otoferlin dual vector systemsDECIBEL THERAPEUTICS INC·Filed 2019·Granted May 30, 2023·9 cites·11 claims
- 0382US12233136B2Myosin 15 promoters and uses thereofDECIBEL THERAPEUTICS INC·Filed 2019·Granted Feb 25, 2025·3 cites·25 claims
- 0480US12331296B2Variant RNAiGENZYME CORP·Filed 2023·Granted Jun 17, 2025·0 cites·23 claims
- 0580US11603529B2Variant RNAiGENZYME CORP·Filed 2018·Granted Mar 14, 2023·1 cites·43 claims
- 0680US10760079B2Variant RNAiGENZYME CORP·Filed 2019·Granted Sep 1, 2020·1 cites·41 claims
- 0780US2024182896A1VARIANT RNAiGENZYME CORP·Filed 2023·Application pending·0 cites
- 0876US2025290075A1VARIANT RNAiGENZYME CORP·Filed 2025·Application pending·0 cites
- 0975US2025127926A1Compositions and methods for treating sensorineural hearing loss using otoferlin dual vector systemsDECIBEL THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1070US10450563B2Variant RNAiGENZYME CORP·Filed 2016·Granted Oct 22, 2019·1 cites·33 claims
- 1170US2024226326A9Compositions and methods for treating sensorineural hearing loss using otoferlin dual vector systemsDECIBEL THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1269US11781137B2Variant RNAiGENZYME CORP·Filed 2020·Granted Oct 10, 2023·0 cites·31 claims
- 1366US2024309399A1Methods and compositions for administering otoferlin dual vector systemsDECIBEL THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1465US12410442B2Compositions and methods for treating sensorineural hearing loss using otoferlin dual vector systemsDECIBEL THERAPEUTICS INC·Filed 2021·Granted Sep 9, 2025·0 cites·19 claims
- 1560US2025304637A1Myosin 15 promoters and uses thereofDECIBEL THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 1657US2025319205A1Myosin 15 promoters and uses thereofDECIBEL THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 1752US2024226331A9Methods and compositions for reducing nucleic acid vector-induced toxicity in the inner earDECIBEL THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1851US2024148905A1Methods for treating sensorineural hearing loss using otoferlin dual vector systemsDECIBEL THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1938US2003215805A1Novel genes, compositions, kits, and methods for identification, assessment prevention, and therapy of breast cancerMILLENNIUM PHARM INC·Filed 2002·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Adam Palermo files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →